Study finds more parents saying ‘No’ to vitamin K, putting babies’ brains at risk
Highlights:A new review of research has found the number of parents refusing vitamin K injections for their newborns is on...
Disability
10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders
SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of...
Cochlear North America Celebrates International Cochlear Implant Day with Announcement of 2026 Academic Scholarship Recipients
LONE TREE, Colo., Feb. 25, 2026 /PRNewswire/ -- In celebration of International Cochlear Implant Day, Cochlear North America is proud...
Autodesk and U.S. Paralympian, CEO & founder of BioDapt, Mike Schultz, announce partnership to advance next-generation prosthetics
SAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ -- Following his final competition in Cortina next month, three-time U.S. Paralympic medalist, designer and...
Dr. Drew Brown IV Introduces the “Surgery Last, Basics First” Standard for Better Health Decisions
Dr. Drew Brown IV, a Tampa, Florida, orthopedic spine surgeon and founder of DB4Spine, is promoting a simple personal standard...
PACU Day turns Presidents Day into a powerful investment in people
WINSTON-SALEM, N.C., Feb. 18, 2026 /PRNewswire/ -- Presidents Day is often a time to reflect on leadership and the values that...
FDA Grants PMA Approval to LimiFlex(TM) Dynamic Sagittal Tether
Motion-Preserving Lumbar Spine Surgery - Stabilization Without Fusion for Patients with Degenerative Spondylolisthesis SAN CARLOS, CALIFORNIA / ACCESS Newswire /...
Emperion Achieves SOC 2® Type II Certification
Confirming Commitment to Operational Integrity and Data SecurityWAYNE, Pa., Feb. 17, 2026 /PRNewswire/ -- To underscore its commitment to robust...
Andelyn Biosciences to Apply the AAV Curator® Platform to Manufacture Clinical Grade AAV for Drake Rayden Foundation for the Treatment of Nonketotic Hyperglycinemia
COLUMBUS, Ohio, Feb. 17, 2026 /PRNewswire/ -- Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development...
Long Term Data Published in JAMA Neurology Demonstrate Sustained Efficacy and Consistent Safety of BRIUMVI in Relapsing Multiple Sclerosis
During year 5 of treatment with BRIUMVI the annualized relapse rate was 0.020, equivalent to one relapse occurring every 50...
BioRestorative Announces Positive Outcome from Type B Meeting with FDA
BioRestorative completed a Type B meeting with the U.S. Food and Drug Administration (“FDA”) regarding a potential accelerated Biologics License...
BioRestorative Announces Positive Outcome from Type B Meeting with FDA
BioRestorative completed a Type B meeting with the U.S. Food and Drug Administration (“FDA”) regarding a potential accelerated Biologics License...
SEISMIC consortium secures EUR 23.5 million IHI grant to pioneer next-generation minimally invasive brain treatments
Members of the SEISMIC project team Members of the SEISMIC project team SEISMIC Kickoff Meeting at Philips in Best, the...
SEISMIC consortium secures EUR 23.5 million IHI grant to pioneer next-generation minimally invasive brain treatments
Members of the SEISMIC project team Members of the SEISMIC project team SEISMIC Kickoff Meeting at Philips in Best, the...
InfiniHealth Medical Group Announces Integrated Multispecialty Care Model to Support Coordinated Specialty Services Across New Jersey
WEST ORANGE, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- InfiniHealth Medical Group today announced the continued advancement of its integrated...
InfiniHealth Medical Group Announces Integrated Multispecialty Care Model to Support Coordinated Specialty Services Across New Jersey
WEST ORANGE, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- InfiniHealth Medical Group today announced the continued advancement of its integrated...
BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease
Largest FDA-authorized Phase 2 cell therapy trial conducted in chronic lumbar disc diseaseThe study has enrolled a total of 99...
Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange
Additional exchange listing expected to increase token access and contribute to expanded secondary market liquidity for RAIN Nes-Ziona, Israel, Feb....
PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents
Vancouver, British Columbia--(Newsfile Corp. - February 9, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is...
Roche’s fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)
Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the...